EUVIMEDEUVIMED entdecken
Crossref

Solid-State Evaluation of a Newly Emerged Polymorph for Early-Stage Pharmaceutical Development

Wei Zhang iD, Antonio DiPasquale, Jerry Phan, Cheng W Chiang, Jia Liu, Po-Chang Chiang, Allen Y Hong iD, Shijia Tang iD, Hao Helen Hou, Karthik Nagapudi, Joseph W Lubach iD

Molecular Pharmaceutics · 2025

DOI: 10.1021/acs.molpharmaceut.5c00037 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2025. Verfasst von Wei Zhang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Synthetic Molecule Pharmaceutical Sciences, Genentech Inc., 1 DNA Way, South San Francisco, California 94080, United States. Hauptthemen laut MEDLINE: Drug Development. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This work presents the solid-state evaluation of a new polymorph (Form M) discovered during the early-stage pharmaceutical development of a new chemical entity GDC-6599. Form screening and active pharmaceutical ingredient (API) crystallization development identified Form A of GDC-6599 as the experimentally most stable polymorph, although more stable polymorphs were predicted by crystal structure prediction (CSP). Later, a new polymorph, Form M, was discovered in the crystallization of a kilogram-scale API batch. The powder X-ray diffraction (PXRD) pattern of Form M was consistent with the calculated pattern of the predicted most stable polymorph (Rank 1) by CSP. Form A and Form M were subsequently speculated as enantiotropic polymorphs according to their melting temperatures and enthalpies. Slurry competition (SC) experimentally confirmed Form M as the more stable polymorph at temperatures relevant to pharmaceutical development. To support API manufacturing, a quantitative PXRD method was successfully developed for controlling the Form A percentage during the API crystallization process. To understand the impact of Form M on the drug product performance, pharmaceutical and biopharmaceutical evaluations were carried out. The intrinsic solubility of Form M was found to be 56% of the intrinsic solubility of Form A, consistent with their calculated solubility ratio based on the Gibbs free energy difference predicted by CSP. Biopharmaceutical assessment further suggested that the observed solubility reduction would not impact the biopharmaceutical performance of GDC-6599 at doses relevant for the proposed clinical studies, providing form selection flexibility for clinical formulation development. Accordingly, Form M was recommended for future API manufacturing and solid dosage form development. Meanwhile, Form A was confirmed to be physically stable in a suspension formulation for extemporaneous preparation and was recommended to support the early cohorts of Phase I clinical studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug DevelopmentCrystallizationSolubilityX-Ray DiffractionChemistry, PharmaceuticalPowder DiffractionCalorimetry, Differential ScanningTransition TemperaturePharmaceutical PreparationsDrug CompoundingPowders

Stichwörter der Autor:innen

biopharmaceuticsenantiotropic polymorphspharmaceuticspolymorphismquantitative PXRD

Substanzen

Pharmaceutical PreparationsPowders

Autor:innen und Institutionen

  • Synthetic Molecule Pharmaceutical Sciences, Genentech Inc., 1 DNA Way, South San Francisco, California 94080, United States.

ORCID-Profile: Wei Zhang, Allen Y Hong, Shijia Tang, Joseph W Lubach

Zitieren

APA

Zhang, W., DiPasquale, A., Phan, J., Chiang, C. W., Liu, J., Chiang, P. C., Hong, A. Y., Tang, S., Hou, H. H., Nagapudi, K., & Lubach, J. W. (2025). Solid-State Evaluation of a Newly Emerged Polymorph for Early-Stage Pharmaceutical Development. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.5c00037

Vancouver

Zhang W, DiPasquale A, Phan J, Chiang CW, Liu J, Chiang PC, et al. Solid-State Evaluation of a Newly Emerged Polymorph for Early-Stage Pharmaceutical Development. Molecular Pharmaceutics. 2025. doi:10.1021/acs.molpharmaceut.5c00037

BibTeX
@article{Zhang2025,
  author = {Zhang, Wei and DiPasquale, Antonio and Phan, Jerry and Chiang, Cheng W and Liu, Jia and Chiang, Po-Chang and Hong, Allen Y and Tang, Shijia and Hou, Hao Helen and Nagapudi, Karthik and Lubach, Joseph W},
  title = {Solid-State Evaluation of a Newly Emerged Polymorph for Early-Stage Pharmaceutical Development},
  journal = {Molecular Pharmaceutics},
  year = {2025},
  doi = {10.1021/acs.molpharmaceut.5c00037}
}
Kostenlos starten →